The World Health Organization (WHO) has recently prequalified the OraQuick® HCV self-test, marking a significant advancement in the global initiative against hepatitis C virus (HCV). This self-test, developed by OraSure Technologies, extends accessibility to testing and diagnosis beyond traditional healthcare settings, aligning with WHO’s goal to eradicate HCV.
Login to read more
